Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04235309 · ClinicalTrials.gov registry record
Physical Resilience: Indicators and Mechanisms in the Elderly (PRIME) Collaborative Phase 2
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 297
- Enrollment target
NCT04235309: Completed study, sponsored by Duke University.
NCT04235309 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 297 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04235309 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 297 participants
- Enrollment target
Study Summary
The purpose of this study is to examine underlying physical resilience (the ability to bounce back) in response to a specific stressor (total knee replacement).
Primary Outcome
As measured by a Garmin device worn by participants
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2020-02-27 |
| Est. Completion | 2023-10-30 |
What the finished NCT04235309 record still lists
NCT04235309 is an observational study that tracks outcomes without assigning an intervention. The registered 297 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT04235309 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04235309 about?
NCT04235309 is a clinical study titled "Physical Resilience: Indicators and Mechanisms in the Elderly (PRIME) Collaborative Phase 2". The purpose of this study is to examine underlying physical resilience (the ability to bounce back) in response to a specific stressor (total knee replacement).
What is the current status of trial NCT04235309?
This trial is currently completed. The enrollment target is 297 participants. The study started on 2020-02-27. Estimated completion is 2023-10-30.
Who is sponsoring clinical trial NCT04235309?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06309160 · 297 participants · NA
COMPASS Across Settings (CAST) for Improving Transition Outcomes for Students With ASD
- NCT06375811 · 297 participants · Phase 3
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
- NCT07222215 · 297 participants · Phase 2
PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)
- NCT06305624 · 298 participants · NA
Implementation of Mobile-based Programs for Alcohol Cessation in Treatment of Alcohol-associated Liver Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI